Apoha emerges from stealth with $36M to build “Liquid State Intelligence” for molecular behaviour
Summary
Apoha, a deeptech company, has secured \$36 million in funding to advance its "Liquid State Intelligence" platform. This technology measures how molecules behave under real-world conditions, addressing a long-standing gap in molecular science beyond sequence and structure. Its first product, VIBE®, generates over 1,000 empirical descriptors from tiny samples by capturing wave patterns under stress. This allows companies like Boehringer Ingelheim and Ethris to predict drug failures with over 90% precision or optimize food formulations, saving significant time and costs in pharma, food, and materials sectors. The funding, led by Singular, will scale this foundational data class for physical-world AI.
Key takeaway
For Research Scientists evaluating new drug candidates or material formulations, Apoha's VIBE® platform offers a critical advantage. You can predict product failures with high precision, such as identifying high-risk antibody candidates with over 90% accuracy from just 8 micrograms of material. This capability significantly reduces development costs and accelerates time-to-market by preventing costly late-stage failures.
Key insights
Apoha's Liquid State Intelligence measures molecular behavior under real-world conditions, creating a new data class for physical-world AI.
Principles
- Molecular behavior is a measurable data class.
- Real-world conditions reveal critical product failures.
- Physical-world AI requires empirical matter data.
Method
The VIBE® platform suspends a pin-head sized sample in liquid, applies controlled stresses, and captures wave patterns to generate over 1,000 empirical behavioral descriptors in minutes.
In practice
- Identify high-risk antibody candidates with >90% precision.
- Improve in-vitro to in-vivo correlation for mRNA delivery.
- Rapidly find protein replacements for food products.
Topics
- Liquid State Intelligence
- Molecular Behavior
- VIBE Platform
- Deeptech Funding
- Drug Discovery
- Materials Science
- Food Science
Best for: AI Scientist, Research Scientist, Investor
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Tech.eu - Tech.eu.